CS
IMGN

Credit Suisse’s Immunogen Inc IMGN Stock Holding History

Credit Suisse’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-417,277
Closed -$12.4M – 3066
2023
Q4 		$12.4M Buy
417,277
+124,236
+42% +$2.47M 0.01% 833
2023
Q3 		$4.65M Sell
293,041
-24,678
-8% -$410K ﹤0.01% 1316
2023
Q2 		$6M Buy
317,719
+32,334
+11% +$382K 0.01% 1219
2023
Q1 		$1.1M Sell
285,385
-4,720
-2% -$20.1K ﹤0.01% 2266
2022
Q4 		$1.44M Buy
290,105
+12,436
+4% +$67.4K ﹤0.01% 2090
2022
Q3 		$1.33M Buy
277,669
+20,624
+8% +$109K ﹤0.01% 2121
2022
Q2 		$1.16M Sell
257,045
-12,205
-5% -$53K ﹤0.01% 2286
2022
Q1 		$1.28M Buy
269,250
+4,364
+2% +$24.2K ﹤0.01% 2380
2021
Q4 		$1.97M Buy
264,886
+13,965
+6% +$86.8K ﹤0.01% 2799
2021
Q3 		$1.42M Buy
250,921
+10,232
+4% +$59.1K ﹤0.01% 3072
2021
Q2 		$1.59M Sell
240,689
-13,867
-5% -$96.7K ﹤0.01% 3033
2021
Q1 		$2.06M Sell
254,556
-114,883
-31% -$938K ﹤0.01% 2801
2020
Q4 		$2.38M Buy
369,439
+5,921
+2% +$34.5K ﹤0.01% 2690
2020
Q3 		$1.31M Sell
363,518
-47,405
-12% -$191K ﹤0.01% 2736
2020
Q2 		$1.89M Buy
410,923
+306,288
+293% +$1.3M ﹤0.01% 2426
2020
Q1 		$357K Sell
104,635
-8,980
-8% -$39.3K ﹤0.01% 3306
2019
Q4 		$580K Buy
113,615
+14,174
+14% +$48.1K ﹤0.01% 3471
2019
Q3 		$240K Buy
99,441
+13,740
+16% +$36.5K ﹤0.01% 3797
2019
Q2 		$186K Sell
85,701
-42,093
-33% -$99.5K ﹤0.01% 3858
2019
Q1 		$346K Buy
127,794
+2,771
+2% +$12K ﹤0.01% 3539
2018
Q4 		$601K Sell
125,023
-19,409
-13% -$118K ﹤0.01% 3149
2018
Q3 		$1.37M Sell
144,432
-45,402
-24% -$436K ﹤0.01% 2631
2018
Q2 		$1.85M Buy
189,834
+56,675
+43% +$597K ﹤0.01% 2538
2018
Q1 		$1.4M Buy
133,159
+5,366
+4% +$53K ﹤0.01% 2713
2017
Q4 		$818K Sell
127,793
-15,644
-11% -$96.5K ﹤0.01% 3137
2017
Q3 		$1.1M Buy
143,437
+14,456
+11% +$96.1K ﹤0.01% 3027
2017
Q2 		$917K Buy
128,981
+55,413
+75% +$254K ﹤0.01% 2762
2017
Q1 		$284K Sell
73,568
-110,883
-60% -$324K ﹤0.01% 3532
2016
Q4 		$376K Buy
184,451
+28,986
+19% +$58.2K ﹤0.01% 3568
2016
Q3 		$417K Sell
155,465
-23,927
-13% -$69.6K ﹤0.01% 3519
2016
Q2 		$553K Buy
179,392
+68,616
+62% +$430K ﹤0.01% 3361
2016
Q1 		$944K Buy
110,776
+58,008
+110% +$491K ﹤0.01% 2773
2015
Q4 		$716K Sell
52,768
-18,080
-26% -$223K ﹤0.01% 3097
2015
Q3 		$679K Sell
70,848
-104,278
-60% -$1.52M ﹤0.01% 3162
2015
Q2 		$2.52M Buy
175,126
+46,905
+37% +$515K ﹤0.01% 2358
2015
Q1 		$1.15M Sell
128,221
-57,948
-31% -$420K ﹤0.01% 2860
2014
Q4 		$1.14M Buy
186,169
+128,632
+224% +$1.18M ﹤0.01% 3023
2014
Q3 		$609K Sell
57,537
-171,188
-75% -$1.94M ﹤0.01% 3486
2014
Q2 		$2.71M Buy
228,725
+63,515
+38% +$797K ﹤0.01% 2457
2014
Q1 		$2.47M Buy
165,210
+56,291
+52% +$887K ﹤0.01% 2353
2013
Q4 		$1.6M Sell
108,919
-6,982
-6% -$107K ﹤0.01% 2863
2013
Q3 		$1.97M Buy
115,901
+57,703
+99% +$1.01M ﹤0.01% 2403
2013
Q2 		$965K Buy
+58,198
New +$943K ﹤0.01% 2824

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Credit Suisse's IMGN Position: Q1 2024 in Review

Credit Suisse sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 417,277 shares — an estimated $12.4M sold.

Credit Suisse first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $12.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Credit Suisse reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Credit Suisse sold 417,277 Immunogen Inc shares in Q1 2024, an estimated $12.4M.
  • Credit Suisse first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Credit Suisse's Immunogen Inc position peaked at $12.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.